A Clinical Study on the Treatment of Cerebral Small Vascular Disease

Summary

This study is designed to evaluate the safety and efficacy of butylphthalide (NBP) in the treatment of cerebral small vessel disease through a multicenter, randomized,double-blind, placebo-controlled study. Butylphthalide Soft Capsule and placebo were prescribed to the experimental group and the control group for a period of 24-months, respectively. After that, the experimental group and the control group were given Butylphthalide Soft Capsule for 6 months.

Timeline

Start

2018-04-25

Primary completion

2022-02

Completion

2022-06

Drugs

Indications